Data on performance records of 1249 Frieswal daughters of 71 sires over a period of 13 years from [2000][2001][2002][2003][2004][2005][2006][2007][2008][2009][2010][2011][2012] LL and CI were low (0.17 ± 0.10 and 0.11 ± 0.09
Methods: Forty-one volumes from histologically confirmed endometriomas were retrieved from our database for analysis. A single examiner acquired all the volumes. Another operator evaluate all 41 volumes to compare means obtained from two modalities. In addition, to evaluate the reproducibility in a sample of 20 volumes, two different observers calculated the MGV from cyst content using the VOCAL software. For each methods, each examiner was to review the volumes twice, 3 week apart for assessing intraobserver agreement. In addition the observers recorded the time spent performing each analysis. Inter-and intraobserver reproducibility was evaluated for each method using intraclass correlation coefficients (ICC) with 95% confidence interval (CI). Results: There was no difference in the mean MGV using manual (22.211 ± 7.541) and semiautomated modality of sampling (23.840 ± 8.621, P > 0.05; ICC 0.954). The correlation between manual and semiautomated sampling measurement was high with a R of 0.92. According to ICCs to test reproducibility, there was a not significantly different interobserver reliability using manual (0.931; 95% CI, 0.824-0.973) compared with semiautomated modality of sampling (0.924; 95% CI, 0.809-0.970)) ultrasound. Intraobserver reproducibility for both examiners was good (ICC > 0.94). Semiautomated measurements were obtained significantly faster than those by manual evaluation. Conclusions: Both methods seem reliable but the semiautomated method using the sphere should be preferred because less timeconsuming and used to discriminate ovarian endometriomas from other unilocular ovarian cysts in premenopausal women.
P29.05 Two-year outcome of MRgFUS treatment of adenomyosis
Shinsuma General Hospital, Kobe, JapanObjectives: To evaluate the efficacy of MRgFUS treatment of adenomyosis over a 2-year follow-up, symptom severity, alternative treatment and adverse events were examined. Methods: Thirty-nine women (mean age 40.9 years), with symptomatic adenomyosis who had completed their family planning, were treated with MRgFUS commonly used in the treatment of uterine myoma. During the first year of follow-up, the patients visited our clinic at 1, 3, 6 and 12 months and were given an 8-item questionnaire to determine symptom severity score (SSS). Thereafter, the same questionnaire was mailed to the patients every 6 months. A high SSS indicated severe symptoms. Follow-up was discontinued when patients underwent hormonal treatment, hysterectomy because of treatment failure or became pregnant possibly as a consequence of a change in symptoms. Two patients were lost to follow up at the end of the second year. Results: Within one year of MRgFUS, 2 patients underwent hormonal treatment, 2 underwent hysterectomy and 1 became pregnant (who later underwent a legal abortion). In the subsequent one year, 7 patients underwent hormonal treatment, 1 underwent hysterectomy and 1 became pregnant (who later aborted spontaneously). At the 2-year follow-up, 23 patients needed no major treatment other than pain relievers or...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.